A critical advance in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently lost in many forms of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research